Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 110.3B | 106.5B | 145.2B | 105.0B |
Cost of revenue | 62.5B | 62.3B | — | — |
Gross profit | 47.8B | 44.3B | — | — |
Operating expense | ||||
Research & development | 28.2B | 27.8B | 27.6B | 27.1B |
Selling general and admin | 18.1B | 17.7B | 19.1B | 16.8B |
Other operating expenses | -339.8M | -24.3M | — | — |
Operating income | 1.9B | -1.2B | 11.9B | 6.0B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | 194.2M | 24.3M | — | — |
Pretax income | 3.0B | -873.8M | 27.3B | 3.5B |
Tax provision | 970.8M | 558.2M | — | — |
Net income | 2.3B | -1.5B | 19.7B | 4.2B |
Basic EPS | 0.0 | 0.0 | 0.2 | 0.0 |
Diluted EPS | 0.0 | 0.0 | 0.2 | 0.0 |
Basic average shares | 130.5B | 130.6B | 131.2B | 132.6B |
Diluted average shares | 133.3B | 130.6B | 133.0B | 141.6B |
EBITDA | 8.9B | 5.2B | 32.4B | 6.0B |
Net income from continuing op. | 2.3B | -1.5B | — | — |
Minority interests | -145.6M | 0 | — | — |
Preferred stock dividends | — | — | — | — |